MK-677 Pre-Research Checklist: What to Verify Before You Order

A pre-research checklist for MK-677 is a fixed sequence of verifications a buyer completes before a lot is accepted into inventory: confirm the compound identity on the paperwork matches the purchase order, confirm purity against a batch-matched certificate of analysis that names its analytical method, confirm contamination testing beyond purity, confirm storage and labeling documentation, pin supplier terms down in writing, and resolve your own legal and protocol position with counsel before anything ships. MK-677 (ibutamoren) is a research compound, not an approved drug, and every item below assumes research use only.

The checklist is deliberately procedural. Most sourcing problems in this category are not dramatic — they are quiet documentation gaps that only surface months later, when a lot number on a vial does not appear anywhere in your records and you cannot reconstruct what you actually received. Running the same verification steps on every order, in the same order, is what prevents that.

Start with compound identity, not price

MK-677 is a non-peptide, orally active growth hormone secretagogue studied as a ghrelin receptor agonist. Research suggests it acts on the same receptor pathway as several peptide secretagogues, but structurally it is a small molecule rather than a peptide chain, and that distinction has practical consequences for a buyer. Handling characteristics, documented storage conditions, solubility behaviour and the analytical methods used to characterise it are not interchangeable with what you would expect from a lyophilised peptide. Do not assume a supplier's standard peptide handling sheet applies.

The first verification is boring and non-negotiable: does the chemical identifier on the certificate of analysis match the identifier on your purchase order, and do both match the vial or container label? Research compounds circulate under multiple names, abbreviations and informal trade labels. A supplier who lists a compound by a colloquial name only, with no formal identifier anywhere in the documentation, has given you nothing you can audit later.

Second, separate two questions that get collapsed constantly. Purity asks how much of what is in the container is the intended substance. Identity asks whether the intended substance is actually what is in there at all. A high purity figure attached to the wrong compound is a confident number about the wrong thing. Both questions need their own answer in the paperwork.

The paperwork that should travel with every lot

A certificate of analysis is only useful if it is tied to the specific lot you received. Generic COAs — one document reused across every shipment of a compound, with no lot number or a lot number that never changes — tell you about a batch somebody tested once, not about the batch in your receiving area.

At minimum, look for the lot or batch number printed on the COA and matching the container, the test date, the method used for each result, and the name of the laboratory that performed the work. Purity figures should be attributed to a method such as high-performance liquid chromatography, because a purity percentage with no stated method is a number without a test behind it. Identity confirmation is typically addressed by mass spectrometry, which answers a different question than a purity chromatogram does. Where the supplier can provide the underlying chromatogram rather than a summary line, that is better evidence, not a formality.

Then look past purity entirely. Purity testing describes the proportion of intended compound; it does not characterise the contamination classes that a multi-panel analysis is designed to catch. A supplier who tests one attribute and reports one number is giving you a partial picture of the lot, regardless of how impressive that single number looks.

Finally, ask how you obtain the document. Three patterns should concern you: COAs available only on request after purchase, COAs sold as a paid add-on, and COAs delivered as flattened images with no lab identification and no way to verify them independently. Publicly posted, independently checkable lab results are the standard worth holding suppliers to, because they let you verify before you commit rather than after.

Questions for your attorney before your purchasing team

This section is informational and is not legal advice. The honest framing is that the regulatory position for research-use-only compounds is unsettled in places, varies by jurisdiction, and depends heavily on your specific business model — so the output of this step is not a conclusion, it is a list of questions you put to qualified counsel and, where relevant, your state licensing board.

Worth raising with your attorney: what your existing license or business registration actually authorises you to purchase, hold and resell; whether research-use-only labelling creates obligations on your side when a product is resold; what recordkeeping or chain-of-custody expectations apply to your category of business; how your professional liability coverage treats research compounds; and what your advertising, labelling and claim-making constraints are. In most states these answers depend on the specific license held, so a general answer found online is not a substitute for a board-specific one.

Two additional points belong on the list. First, organisations governing competitive sport have generally prohibited growth hormone secretagogues as a class — if your business touches athletes in any capacity, confirm the current published list directly with the relevant body rather than relying on a summary. Second, if any part of your research program involves animal models, institutional oversight applies and that oversight includes veterinary involvement: talk to your veterinarian and your institution's animal care committee before a protocol is finalised, not after materials arrive.

Terms worth pinning down in writing

Wholesale sourcing fails on terms more often than on chemistry. Before a first order, get written answers on the pricing structure and how tiers are determined, the minimum order requirement, the lead time from approved order to dispatch, where fulfilment originates, and what happens on backorder or discontinuation. Margins, minimums and landed cost vary widely with volume, category and supplier, so treat any figure you are quoted as specific to that quote and get it in writing rather than assuming a market norm.

The question most buyers forget is batch consistency across reorders. Your second order will almost certainly be a different lot. Ask whether each lot carries its own current COA, whether documentation is archived and retrievable by lot number later, and how the supplier notifies partners when a lot changes. A supplier who cannot describe their own lot-tracking process is telling you something useful.

Also confirm the unglamorous operational terms: packaging and cold-chain handling where documented conditions require it, damage and shortage claims, the window for reporting a discrepancy, and whether documentation is included at no cost. Hidden pricing — quotes only after an application, with no published structure — is common in this industry and is not automatically disqualifying, but it does mean you cannot compare suppliers until you have both quotes in hand, which slows every decision you make.

Signals worth checking, side by side

Internal readiness before the first shipment arrives

Supplier verification is half the checklist. The other half is whether your own operation can receive the material without losing track of it. Define, in writing, who is authorised to receive and sign for research compounds, where they are logged, and what gets recorded at intake: lot number, receipt date, quantity, supplier, and the location of the matching COA. If that record does not exist at intake, it will not exist later when you need it.

Storage follows the supplier's documented conditions for that specific compound — not a general rule carried over from a different product class. Research compounds should be physically segregated from anything else your business holds, clearly labelled as research use only, and stored where access is controlled. Decide your records retention period in advance and keep COAs filed against lot numbers rather than against order dates, because lot number is the identifier you will search on.

Finally, write down the disposal and discrepancy procedures before you need them. Knowing in advance what you do with a damaged container, a lot that fails your incoming check, or material at end of life is what keeps a small problem procedural instead of improvised.

What Real Peptides does differently

Real Peptides builds the wholesale program around the parts of this checklist that buyers usually have to chase. Catalog compounds are produced to 99%+ HPLC purity and subjected to 7-panel batch testing, so the documentation covers more than a single purity figure. Certificates of analysis are publicly verifiable — a prospective partner can check lab results independently before applying, rather than requesting them after a purchase or paying for them as an add-on. Fulfilment runs from the United States in 5–7 days, which makes reorder planning a calculation rather than a guess.

The partner path itself is a 3-step wholesale application, structured so qualified businesses can establish terms without an extended negotiation cycle. Buyers evaluating growth hormone secretagogue research can apply every item in this checklist to the catalog directly and compare what comes back against what other suppliers provide. All compounds are supplied for research use only.

Where qualified buyers go from here

If your legal position is settled with counsel, your intake and storage procedures are written down, and you have decided what evidence you require from a supplier before a lot enters inventory, the remaining step is applying to the Wholesale Partner Program and comparing the documentation you receive against the checklist above. Reviewing published COAs first costs nothing and tells you most of what you need to know.

Buyers researching secretagogue pathways often work across related compounds, and the same testing standard applies throughout the catalog — including Ipamorelin 10mg, CJC-1295 No DAC 10mg and Tesamorelin 10mg — while the broader Popular Peptides collection, Growth Factor & Tissue Signaling Research and Performance & Recovery Research ranges give a fuller view of what a wholesale catalog covers.